Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differential gene expression in pituitary adenomas by oligonucleotide array analysis.

Damian G Morris1, Mädälina Musat, Sándor Czirják

  • 1Department of Endocrinology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK.

European Journal of Endocrinology
|July 5, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Central serous chorioretinopathy following intramuscular testosterone therapy in prolactinoma.

Oxford medical case reports·2026
Same author

[<sup>68</sup>Ga]Ga-DOTATATE uptake in pheochromocytoma/paraganglioma predicts SSTR2 expression by immunohistochemistry: Strongest uptake in head and neck paraganglioma.

European journal of nuclear medicine and molecular imaging·2026
Same author

A novel activating somatic mutation in EPAS1, coding for HIF-2α, in a patient with a paraganglioma and sickle cell disease.

Archives of endocrinology and metabolism·2026
Same author

Exploratory Statistical Analyses of Clinical and Biochemical Factors for Differentiated Thyroid Cancer from a Romanian Cohort.

Cancers·2026
Same author

Quality of life in patients with pheochromocytoma and paraganglioma: influence of tumor type, genetics and surgical resection.

European journal of endocrinology·2026
Same author

Personalized Drug Screening and Risk Assessment in Patient-Derived Gastroenteropancreatic Neuroendocrine Neoplasms.

The Journal of clinical endocrinology and metabolism·2026

Gene expression profiling of pituitary adenomas identified novel genes involved in tumor development. Key findings include the upregulation of LAPTM4B and BAG1, and downregulation of p18 in specific adenoma subtypes, offering insights into pituitary tumor pathogenesis.

Area of Science:

  • Endocrinology
  • Oncology
  • Genomics

Background:

  • Pituitary adenomas are the most common intracranial neoplasms.
  • Gene expression profiling offers novel insights into tumor biology.
  • Understanding pituitary adenoma pathogenesis is crucial for diagnosis and treatment.

Purpose of the Study:

  • To investigate gene expression profiles in pituitary adenomas using microarray technology.
  • To identify differentially expressed genes in major pituitary adenoma subtypes.
  • To validate the expression of key genes in a larger cohort of pituitary adenomas.

Main Methods:

  • Utilized Affymetrix GeneChip HG-U133A arrays to analyze gene expression in four major pituitary adenoma subtypes.
  • Compared gene expression profiles against normal pooled pituitary RNA.

Related Experiment Videos

  • Validated differentially expressed genes (LAPTM4B, BAG1, p18) using real-time quantitative PCR.

    • Main Results:

    • Identified 3906 differentially expressed genes and 351 expressed sequence tags across pituitary tumor subtypes.
    • Found significant overexpression of Lysosomal-associated protein transmembrane-4-beta (LAPTM4B) in ACTH-secreting adenomas and NFPAs.
    • Observed significant overexpression of Bcl-2-associated athanogene (BAG1) in GH- and prolactin-secreting adenomas and NFPAs.
    • Noted significant underexpression of p18 in ACTH-secreting adenomas.

    Conclusions:

    • Microarray analysis is a valid approach for identifying genes involved in pituitary adenoma pathogenesis.
    • Specific genes like LAPTM4B, BAG1, and p18 show differential expression patterns in pituitary adenomas.
    • These findings contribute to understanding the molecular mechanisms underlying pituitary tumor development.